The value of serum C-reactive protein, carcinoembryonic antigen and cancer-associated antigen 19.9 as prognostic factors for recurrence in colorectal cancer

Journal of B.U.ON.

Volumn 6, Issue 1, 2001, Pages 91-94

  Kara, E ^a   Korkut, M A ^a   Erhan, Y ^a   Aydede, H ^a   Zeybek, A ^a   Sungurtekin, U ^a   Osmanoglu H ^a  

^a NONE   (Turkey)

Author keywords

C reactive protein; CA 19.9; Carcinoembryonic antigen; Colorectal cancer; Prognosis; Recurrence

Indexed keywords

C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ASCENDING COLON; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; DESCENDING COLON; DISEASE ASSOCIATION; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; RECTUM; SIGMOID; TRANSVERSE COLON; TUMOR LOCALIZATION;

EID: 0035037282     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alfa-fetoprotein: Immunochemical purification and chemical properties. Expression in normal state and malignant and nonmalignant liver disease
2. Patterns of serial CEA assays and their clinical use in the management of colorectal cancer
3. Sequential carcinoembryonic antigen levels: A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer
4. Prognostic value of preoperative serum CEA compared to clinical staging; I: Colorectal carcinoma
5. The role of tumor markers in the management of colorectal cancer
6. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19.9 in the sera of patients as a mucin
7. A monosialogan-glioside is a monoclonal antibody defined antigen of colon carcinoma
8. Gastrointestinal cancer associated antigen in immunoperoxidase assay
9. Presence of antigen in sera of patients with colorectal, gastric and pancreatic carcinoma
10. Alpha-globulins in surveillance of colorectal cancer
11. Acute-phase reactant proteins and carcinoembryonic antigen in cancer of colon and rectum
12. Acute-phase reactant protein profiles: An aid to monitoring large bowel cancer by CEA and serum enzymes
13. Serological reactions in pneumonia with a non-protein somatic fraction of pneumonococcus
14. Biochemical markers in human breast cancer
15. Acute phase reactants and complement components as indicators of recurrence in human cervical cancer
16. Serum prealbumin, retinol-binding protein, transferrin and albumin levels in patients with large bowel cancer
17. Growth inhibition of human melanoma cells by C-reactive protein activated lymphocytes
18. Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human C-reactive protein or crude lymphokine
19. Serum carcinoembryonic antigen and acute-phase reactant proteins in the preoperative detection of fixation of colorectal tumors
20. The effects of malignant and inflammatory fixation on prognosis after rectal excision
21. The role of a questionnaire and four biochemical markers to detect cancer risk in a asymptomatic population
22. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19.9 and carcinoembryonic antigen
23. Carcinoembryonic antigen, ferritin and tissue polypeptide antigen in serum and tissue; Relationship with the receptor content in breast carcinoma
24. Value of alpha1-acid glycoprotein assay in the detection of human colorectal cancer: Comparison with carcinoembryonic antigen
25. The levels of alpha1- antitrypsin and alpha1-antichymotrypsin in the sera of patients with gastrointestinal cancer during diagnosis
26. Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer
27. Sensitivity and specificity of CA 242 in gastrointestinal cancer. A comparison with CEA, CA 50, and CA 19.9
28. The use of tumor markers CEA, CA 195 and CA 242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer
29. An evaluation of CEA test for monitoring patients with resected colon cancer
30. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer
31. Tumor markers concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance
32. Radioimmunoguided surgery for recurrent cancer manifested by isolated CEA elevation